ALHC vs. GH: A Head-to-Head Stock Comparison

Company Overview

GH stands out with 4.60 billion USD in market value—about 1.52× ALHC’s market cap of 3.03 billion USD.

With betas of 1.33 for ALHC and 1.49 for GH, both show similar volatility profiles relative to the overall market.

Performance Comparison

This chart compares the performance of ALHC and GH over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Hover over the lines to see the investment’s value and total return (%) at specific dates.

Data is adjusted for dividends and splits.

Valuation Metrics Comparison

The section examines key financial ratios to assess the valuation of ALHC and GH based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.

• Neither ALHC nor GH turned a profit—both carry negative P/E ratios of -32.75 and -11.03, underscoring continued losses that pressure their valuations.
• ALHC posts a negative forward PEG of -1.11, hinting at anticipated earnings decline, whereas GH at 0.46 has projections for stable or growing earnings.
• GH carries a sub-zero price-to-book ratio of -18.32, indicating negative equity. In contrast, ALHC (P/B 27.45) has positive book value.
• GH reports a negative Price-to-Free Cash Flow ratio of -15.07, showing a cash flow shortfall that could threaten its operational sustainability, while ALHC at 159.00 maintains positive cash flow.

Dividend Comparison

Neither ALHC nor GH currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.

Financial Strength Metrics Comparison

This section dives into the financial resilience of ALHC and GH, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.

• GH has negative equity (debt-to-equity ratio -5.21), suggesting asset shortfalls, whereas ALHC at 0.07 preserves healthier equity coverage.
• GH carries a debt-to-assets ratio of 0.97, suggesting substantial asset funding via debt, while ALHC at 0.01 opts for a more conservative financing structure.
• Both ALHC and GH report negative interest coverage ratios (-2.98, -166.83), meaning EBIT itself is negative—neither can cover interest, a critical solvency warning.